Similar articles

• The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

  Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV. Fahey JL, et al. N Engl J Med. 1990 Jan 18;322(3):166-72. doi: 10.1056/NEJM199001183220305. N Engl J Med. 1990. PMID: 1967191
• Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.

  Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J, et al. Jacobson MA, et al. BMJ. 1991 Jan 12;302(6768):73-8. doi: 10.1136/bmj.302.6768.73. BMJ. 1991. PMID: 1671651 Free PMC article.
• The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

  [No authors listed] [No authors listed] Dis Markers. 1990 May-Jun;8(3):164-5. Dis Markers. 1990. PMID: 2125538 No abstract available.
• Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.

  Fuchs D, Krämer A, Reibnegger G, Werner ER, Dierich MP, Goedert JJ, Wachter H. Fuchs D, et al. Infection. 1991;19 Suppl 2:S98-102. doi: 10.1007/BF01644476. Infection. 1991. PMID: 1673120 Review.
• Markers for progression in HIV infection.

  Lange JM, de Wolf F, Goudsmit J. Lange JM, et al. AIDS. 1989;3 Suppl 1:S153-60. doi: 10.1097/00002030-198901001-00023. AIDS. 1989. PMID: 2575397 Review. No abstract available.